COVID-19 Project Team: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 32: Line 32:
* [[user:Nuha|Nuha AL-Howthi, MD]]
* [[user:Nuha|Nuha AL-Howthi, MD]]
* [[User:Ifrah Fatima|Ifrah Fatima, M.B.B.S]]
* [[User:Ifrah Fatima|Ifrah Fatima, M.B.B.S]]
*[[Ogechukwu Hannah Nnabude, MD]]


'''Frequently Asked Outpatient Questions Team Members'''
'''Frequently Asked Outpatient Questions Team Members'''
Line 65: Line 66:
'''Pulmonary Disorders and COVID-19 Team Members'''
'''Pulmonary Disorders and COVID-19 Team Members'''


*Ayesha Farheen Javid
* Ayesha Farheen Javid
 
* Usman Aliakbar


'''Radiologic Manifestations of COVID-19 Team Members'''
'''Radiologic Manifestations of COVID-19 Team Members'''

Revision as of 04:19, 12 June 2020

COVID-19 Project
Introduction
Team
Meetings' Summary
Topics
Ongoing Clinical Trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Meet The Team

Associate Editor(s)-in-Chief:

Cardiovascular Disorders of COVID-19 Team Members

Dermatologic Disorders of COVID-19 Team Members

Frequently Asked Inpatient Questions Team Members

Frequently Asked Outpatient Questions Team Members

Gastrointestinal disorders and of COVID-19

Hematologic disorders of COVID-19 Team Members

Nephrologic Disorders of COVID-19 Team Members


Neurologic Disorders and COVID-19 Team Members

Ongoing Clinical Trials of COVID-19 Team Members


Pediatrics and COVID-19

Pulmonary Disorders and COVID-19 Team Members

  • Ayesha Farheen Javid
  • Usman Aliakbar

Radiologic Manifestations of COVID-19 Team Members


Other Team Members